"With our deep understanding of NK cells, we aim to be the first to truly therapeutically harness the cancer-fighting abilities of these remarkable white blood cells. For more information on oNKo-innate, visit www.onko-innate.com."
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze